BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 25308750)

  • 1. Spironolactone decreases the somatic signs of opiate withdrawal by blocking the mineralocorticoid receptors (MR).
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Toxicology; 2014 Dec; 326():36-43. PubMed ID: 25308750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid receptor but not mineralocorticoid receptor mediates the activation of ERK pathway and CREB during morphine withdrawal.
    Navarro-Zaragoza J; Laorden ML; Milanés MV
    Addict Biol; 2017 Mar; 22(2):342-353. PubMed ID: 26598419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRF₂ mediates the increased noradrenergic activity in the hypothalamic paraventricular nucleus and the negative state of morphine withdrawal in rats.
    Navarro-Zaragoza J; Núñez C; Ruiz-Medina J; Laorden ML; Valverde O; Milanés MV
    Br J Pharmacol; 2011 Feb; 162(4):851-62. PubMed ID: 20973778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of morphine and morphine withdrawal on brainstem neurons innervating hypothalamic nuclei that control the pituitary-adrenocortical axis in rats.
    Laorden ML; Castells MT; Milanés MV
    Br J Pharmacol; 2002 May; 136(1):67-75. PubMed ID: 11976269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptors participate in the opiate withdrawal-induced stimulation of rats NTS noradrenergic activity and in the somatic signs of morphine withdrawal.
    Navarro-Zaragoza J; Hidalgo JM; Laorden ML; Milanés MV
    Br J Pharmacol; 2012 Aug; 166(7):2136-47. PubMed ID: 22364199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group: role of ERK1/2.
    Núñez C; Laorden ML; Milanés MV
    Endocrinology; 2007 Dec; 148(12):5780-93. PubMed ID: 17823252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac adverse effects of naloxone-precipitated morphine withdrawal on right ventricle: role of corticotropin-releasing factor (CRF) 1 receptor.
    Navarro-Zaragoza J; Martínez-Laorden E; Mora L; Hidalgo J; Milanés MV; Laorden ML
    Toxicol Appl Pharmacol; 2014 Feb; 275(1):28-35. PubMed ID: 24398105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of 3',5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos expression and tyrosine hydroxylase levels during morphine withdrawal in the hypothalamic paraventricular nucleus and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Milanés MV
    J Neurochem; 2005 Jan; 92(2):246-54. PubMed ID: 15663473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of corticotropin-releasing factor receptor-1 antagonists on the brain stress system responses to morphine withdrawal.
    Navarro-Zaragoza J; Núñez C; Laorden ML; Milanés MV
    Mol Pharmacol; 2010 May; 77(5):864-73. PubMed ID: 20159948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine withdrawal-induced c-fos expression in the hypothalamic paraventricular nucleus is dependent on the activation of catecholaminergic neurones.
    Laorden ML; Núñez C; Almela P; Milanés MV
    J Neurochem; 2002 Oct; 83(1):132-40. PubMed ID: 12358736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN.
    Benavides M; Laorden ML; García-Borrón JC; Milanés MV
    Eur J Neurosci; 2003 Jan; 17(1):103-12. PubMed ID: 12534973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PKC-alpha,gamma isoforms in regulation of c-Fos and TH expression after naloxone-induced morphine withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups.
    Benavides M; Laorden ML; Marín MT; Milanés MV
    J Neurochem; 2005 Dec; 95(5):1249-58. PubMed ID: 16190878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
    Martínez-Laorden E; Hurle MA; Milanés MV; Laorden ML; Almela P
    J Pharmacol Exp Ther; 2012 Sep; 342(3):665-75. PubMed ID: 22647273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.
    Almela P; Cerezo M; González-Cuello A; Milanés MV; Laorden ML
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):293-303. PubMed ID: 17216288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal.
    Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R
    Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein kinase C but not protein kinase A attenuates morphine withdrawal excitation of rat hypothalamus-pituitary-adrenal axis.
    Cerezo M; Laorden ML; Milanés MV
    Eur J Pharmacol; 2002 Sep; 452(1):57-66. PubMed ID: 12323385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of FosB/DeltaFosB in the brain stress system-related structures during morphine dependence and withdrawal.
    Núñez C; Martín F; Földes A; Luisa Laorden M; Kovács KJ; Victoria Milanés M
    J Neurochem; 2010 Jul; 114(2):475-87. PubMed ID: 20438612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal.
    Fuertes G; Laorden ML; Milanés MV
    Neuroendocrinology; 2000 Jan; 71(1):60-7. PubMed ID: 10644900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine hydroxylase phosphorylation after naloxone-induced morphine withdrawal in the left ventricle.
    Almela P; Victoria Milanés M; Luisa Laorden M
    Basic Res Cardiol; 2009 Jul; 104(4):366-76. PubMed ID: 19104749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.